SEC Company Response from PALISADE BIO, INC. (PALI) (CIK 0001357459) (PALI) — Aug 17, 2006
PALISADE BIO, INC. (PALI) (CIK 0001357459)
Date: Aug. 17, 2006 · CIK: 0001357459 · Accession: 0001144204-06-034338
AI Filing Summary & Sentiment
File numbers found in text: 333-132923
Show Raw Text
CORRESP
1
filename1.htm
Sonia
Barros
Division
of Corporation Finance
Telephone
Number: (202) 551-3655
Telecopier
Number: (202) 772-9217
RE:
Neuralstem,
Inc.
Amendment
No. 3
to Registration Statement on Form SB-2
Filed
August 10, 2006
File
No. 333-132923
Dear
Ms.
Barros:
We
are
submitting this letter in response to your comments of August 15, 2006.
The
following are our proposed responses to be included in our fourth amendment
to
the SB2 for
Neuralstem, Inc. I will forward under separate cover the actually proposed
change. This correspondence will follow the lineal order of your letter and
each
specific area addressed, utilizing the text of your letter as the primary
guide:
Management’s
Discussion and Analysis and Plan of Operation, pages
23-28
11.
We
note your response to our prior comment 5 and reissue that comment.
We
refer to your statement on page 24 that you “anticipate that [you] will
approach market makers in order for them to quote [your] securities” and
that “in the event [your] securities become quoted, [you] will be subject
to the periodic reporting requirements of the Securities Act of 1934.”
These statements are currently inaccurate. Your securities do not
have to
be “quoted for you to be subject to the periodic reporting requirements
of
the Securities Exchange Act of 1934. Once his registration statement
becomes effective, you will be subject to the periodic reporting
requirements of the Securities Exchange Act of 1934, whether or not
your
securities are quoted. In addition, the market makers are not the
quotation medium. The OTCBB would be the quotation medium. Market
Makers
may apply to have your securities quoted on the OTCBB. Please revise
your
disclosure accordingly.
Proposed
Response: We
have removed the reference to our securities being quoted and have revised
the
disclosure to accurately state that we will be subject to the reporting
requirements of the Exchange Act upon the registration statement becoming
effective.
Signatures
11.
We
note your response to our prior comment 7 and reissue that comment.
You
revised signatures still do not comply with the signatures requirements
of
Form SB-2. Please revise Mr. Garr’s third signature to indicate he is also
the company’s principal accounting officer and signing for himself in that
capacity. In addition, please note that his second signature on behalf
of
the company is unnecessary, unless required by the company’s governing
documents.
Proposed
Response: We
have clearly indicated that Mr. Garr is signing in his capacity as the principal
accounting officers.
Interim
Financial Statements, page F-17
Note
4: Registration Rights Liability, page F-21
11.
We
acknowledge your response to our previous comment 17. Please address
the
following additional comments:
a.
Please
revise your registration rights disclosure here and on page 46 to
clearly
indicate that your one percent for each 30-day period penalties are
prorated for partial periods as indicated in Section 8(c) of your
Subscription Agreement for your March private
placement.
Proposed
Response: We
have revised the disclosure to clearly indicate that the penalties are prorated
for partial periods.
b.
Please
explain to us how you calculated the 33,000 shares of common stock
to be
issued under the registration rights as a result of your late filing
of
your initial registration statement on Form SB-2. It would appear
that a
1% penalty on 5 million shares would be 50,000 shares issuable per
30-day
period. Based on the February 23, 2006 private placement closing
date you
disclose it appears that the most days you can accrue as of March
31, 2006
is six days. A six day penalty would appear to be only 10,000 shares
while
a total nine day penalty would appear to be 15,000 shares, based
on the
April 3, 2006 filing date. Additionally, please clarify your disclosures
to indicate that the penalty starts to be assessed subsequent to
the
initial 30-day grace period.
Proposed
Response: We
have clarified our disclosure to indicate that we have already accrued a penalty
of 9 days and that the penalty starts to be assessed subsequent to the initial
30 day-grace period.
Exhibits,
page II-4
11.
We
acknowledge your response to our previous comment 10. It appears
that you
list your investment agreement with Regal One as both Exhibits 4.6
and
4.17. Please confirm to us that the only difference between the two
agreements is that Exhibit 4.6 is unexecuted. If true, please revise
your
Exhibit list to remove the unexecuted document. Please explain to
us any
other differences between the two documents and revise your Exhibit
list
to clarify why two agreements are
necessary.
Proposed
Response: We have removed the reference to Exhibit 4.6 from the Exhibit Table.
We are also confirming that the only difference between the two agreements
is
the inclusion of signatures.